These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1376 related articles for article (PubMed ID: 15947137)

  • 1. Complete replication of hepatitis C virus in cell culture.
    Lindenbach BD; Evans MJ; Syder AJ; Wölk B; Tellinghuisen TL; Liu CC; Maruyama T; Hynes RO; Burton DR; McKeating JA; Rice CM
    Science; 2005 Jul; 309(5734):623-6. PubMed ID: 15947137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of the Vero cell culture system that can produce infectious HCV particles.
    Guo J; Yan R; Xu G; Li W; Zheng C
    Mol Biol Rep; 2009 Jan; 36(1):111-20. PubMed ID: 17960493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins.
    Ishii K; Murakami K; Hmwe SS; Zhang B; Li J; Shirakura M; Morikawa K; Suzuki R; Miyamura T; Wakita T; Suzuki T
    Biochem Biophys Res Commun; 2008 Jul; 371(3):446-50. PubMed ID: 18445476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic and functional organization of hepatitis C virus (HCV) glycoprotein E2 on infectious HCV virions.
    Keck ZY; Xia J; Cai Z; Li TK; Owsianka AM; Patel AH; Luo G; Foung SK
    J Virol; 2007 Jan; 81(2):1043-7. PubMed ID: 17079294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles.
    Doerrbecker J; Friesland M; Riebesehl N; Ginkel C; Behrendt P; Brown RJ; Ciesek S; Wedemeyer H; Sarrazin C; Kaderali L; Pietschmann T; Steinmann E
    Hepatology; 2014 Aug; 60(2):508-20. PubMed ID: 24771613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells.
    Witteveldt J; Evans MJ; Bitzegeio J; Koutsoudakis G; Owsianka AM; Angus AG; Keck ZY; Foung SK; Pietschmann T; Rice CM; Patel AH
    J Gen Virol; 2009 Jan; 90(Pt 1):48-58. PubMed ID: 19088272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel function of CD81 in controlling hepatitis C virus replication.
    Zhang YY; Zhang BH; Ishii K; Liang TJ
    J Virol; 2010 Apr; 84(7):3396-407. PubMed ID: 20089661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status and future development of infectious cell-culture models for the major genotypes of hepatitis C virus: Essential tools in testing of antivirals and emerging vaccine strategies.
    Ramirez S; Bukh J
    Antiviral Res; 2018 Oct; 158():264-287. PubMed ID: 30059723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of mouse hepatocyte lines permissive for hepatitis C virus (HCV).
    Aly HH; Oshiumi H; Shime H; Matsumoto M; Wakita T; Shimotohno K; Seya T
    PLoS One; 2011; 6(6):e21284. PubMed ID: 21731692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity.
    Keck ZY; Li SH; Xia J; von Hahn T; Balfe P; McKeating JA; Witteveldt J; Patel AH; Alter H; Rice CM; Foung SK
    J Virol; 2009 Jun; 83(12):6149-60. PubMed ID: 19321602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding.
    Triyatni M; Vergalla J; Davis AR; Hadlock KG; Foung SK; Liang TJ
    Virology; 2002 Jun; 298(1):124-32. PubMed ID: 12093180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.
    Lohmann V; Körner F; Koch J; Herian U; Theilmann L; Bartenschlager R
    Science; 1999 Jul; 285(5424):110-3. PubMed ID: 10390360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI.
    Dreux M; Pietschmann T; Granier C; Voisset C; Ricard-Blum S; Mangeot PE; Keck Z; Foung S; Vu-Dac N; Dubuisson J; Bartenschlager R; Lavillette D; Cosset FL
    J Biol Chem; 2006 Jul; 281(27):18285-95. PubMed ID: 16675450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection.
    Crotta S; Brazzoli M; Piccioli D; Valiante NM; Wack A
    J Hepatol; 2010 Feb; 52(2):183-90. PubMed ID: 20015567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible system in human hepatoma cell lines for hepatitis C virus production.
    Lim SP; Soo HM; Tan YH; Brenner S; Horstmann H; MacKenzie JM; Ng ML; Lim SG; Hong Wj
    Virology; 2002 Nov; 303(1):79-99. PubMed ID: 12482660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus (HCV)-induced immunoglobulin hypermutation reduces the affinity and neutralizing activities of antibodies against HCV envelope protein.
    Machida K; Kondo Y; Huang JY; Chen YC; Cheng KT; Keck Z; Foung S; Dubuisson J; Sung VM; Lai MM
    J Virol; 2008 Jul; 82(13):6711-20. PubMed ID: 18417597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement.
    Chen Z; Zhu Y; Ren Y; Tong Y; Hua X; Zhu F; Huang L; Liu Y; Luo Y; Lu W; Zhao P; Qi Z
    PLoS One; 2011 Apr; 6(4):e18933. PubMed ID: 21526201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection.
    Bose M; Mullick R; Das S; Das S; Karande AA
    Virus Res; 2016 Sep; 224():46-57. PubMed ID: 27574733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein.
    Owsianka AM; Tarr AW; Keck ZY; Li TK; Witteveldt J; Adair R; Foung SKH; Ball JK; Patel AH
    J Gen Virol; 2008 Mar; 89(Pt 3):653-659. PubMed ID: 18272755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.
    Bartosch B; Dubuisson J; Cosset FL
    J Exp Med; 2003 Mar; 197(5):633-42. PubMed ID: 12615904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.